Staged Surgery for Synchronous Proximal Gastric Adenocarcinoma and Pancreatic Head Ductal Adenocarcinoma with an Early Favorable Outcome: A Case Report
- 1FSBI “National Medical Research Radiological Center” of the Ministry of Health of the Russian Federation (FSBI “NMRRC”), 4 Koroleva Street, Obninsk 249036, Russia
- 2Department of Oncology and Roentgenoradiology named after Academician V. P. Kharchenko, Institute of Medicine, Peoples’ Friendship University of Russia—RUDN University, 6 Miklukho-Maklaya Street, Moscow 117198, Russia
Abstract
Background. Synchronous primary gastric cancer and pancreatic ductal adenocarcinoma (PDAC) are uncommon, and published experience with their combined treatment is limited. Proximal gastric adenocarcinoma combined with pancreatic head PDAC presents a particular challenge because resection and reconstruction must address two anatomically separate primary tumors. Materials and Methods. A 62-year-old man with poorly differentiated proximal gastric adenocarcinoma (cT3N0M0) and pancreatic head PDAC (cT3N1M0) received six cycles of neoadjuvant FOLFIRINOX. Preoperative ECOG performance status was 0. Treatment comprised proximal gastrectomy with D2 lymphadenectomy and double-tract reconstruction and, approximately 10 weeks later, pylorus-preserving pancreatoduodenectomy. Contrast-enhanced CT before the second stage showed no disease progression. Results. Intra-abdominal hemorrhage after proximal gastrectomy required relaparotomy. Histopathological examination confirmed microscopically negative resection margins (R0) for both tumors. Gastric tumor regression was Becker grade 3, indicating minimal or no regression; pancreatic regression was Modified Ryan score 3, indicating a poor or absent response. Six cycles of adjuvant modified FOLFIRINOX were reported. At the last reported follow-up, 10 months after the second operation, the patient had no evidence of progression and an ECOG performance status of 0. Conclusions. This case documents the technical feasibility of staged gastric and pancreatic resection after neoadjuvant chemotherapy in a patient with preoperative ECOG performance status 0, with histologically negative resection margins and an early favorable outcome despite a postoperative complication. The reported R0 status describes the morphological assessment of resection margins. Longer follow-up is required to assess durable disease control.
Related
- Primary adrenal small cell neuroendocrine carcinoma in a patient with sarcoidosis and synchronous colon adenocarcinoma
- Synchronous lung adenocarcinoma and pulmonary carcinoid tumorlets in different lobes: a case report
- Patients Undergoing Proximal Hamstring Repair Have High Rates of Return to Work and Favorable Outcomes: A Systematic Review.
- Larger Non-metastatic No. 8 Lymph Node Size Is Associated With Favorable Prognosis After Pancreaticoduodenectomy for Pancreatic Cancer.
- Synchronous Small Cell and Adenocarcinoma of the Lung Integrating Morphology and Molecular Profiling: A Case Report
BibTeX
@article{sokolov2026staged,
title = {{Staged Surgery for Synchronous Proximal Gastric Adenocarcinoma and Pancreatic Head Ductal Adenocarcinoma with an Early Favorable Outcome: A Case Report}},
author = {Pavel V. Sokolov and Mikhail B. Potievskiy and Danil V. Podluzhniy and Andrey B. Ryabov and Mikhail E. Rozhkov and Viltaliy Yu. Skoropad and Aleksei A. Nevolskikh and Sergei A. Ivanov and Peter V. Shegai and Andrei D. Kaprin},
journal = {Journal of Clinical Medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15208119},
url = {https://www.mdpi.com/2077-0383/15/20/8119},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Staged Surgery for Synchronous Proximal Gastric Adenocarcinoma and Pancreatic Head Ductal Adenocarcinoma with an Early Favorable Outcome: A Case Report
AU - Pavel V. Sokolov
AU - Mikhail B. Potievskiy
AU - Danil V. Podluzhniy
AU - Andrey B. Ryabov
AU - Mikhail E. Rozhkov
AU - Viltaliy Yu. Skoropad
AU - Aleksei A. Nevolskikh
AU - Sergei A. Ivanov
AU - Peter V. Shegai
AU - Andrei D. Kaprin
PY - 2026
DA - 2026/10/01
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15208119
UR - https://www.mdpi.com/2077-0383/15/20/8119
AB - Background. Synchronous primary gastric cancer and pancreatic ductal adenocarcinoma (PDAC) are uncommon, and published experience with their combined treatment is limited. Proximal gastric adenocarcinoma combined with pancreatic head PDAC presents a particular challenge because resection and reconstruction must address two anatomically separate primary tumors. Materials and Methods. A 62-year-old man with poorly differentiated proximal gastric adenocarcinoma (cT3N0M0) and pancreatic head PDAC (cT3N1M0) received six cycles of neoadjuvant FOLFIRINOX. Preoperative ECOG performance status was 0. Treatment comprised proximal gastrectomy with D2 lymphadenectomy and double-tract reconstruction and, approximately 10 weeks later, pylorus-preserving pancreatoduodenectomy. Contrast-enhanced CT before the second stage showed no disease progression. Results. Intra-abdominal hemorrhage after proximal gastrectomy required relaparotomy. Histopathological examination confirmed microscopically negative resection margins (R0) for both tumors. Gastric tumor regression was Becker grade 3, indicating minimal or no regression; pancreatic regression was Modified Ryan score 3, indicating a poor or absent response. Six cycles of adjuvant modified FOLFIRINOX were reported. At the last reported follow-up, 10 months after the second operation, the patient had no evidence of progression and an ECOG performance status of 0. Conclusions. This case documents the technical feasibility of staged gastric and pancreatic resection after neoadjuvant chemotherapy in a patient with preoperative ECOG performance status 0, with histologically negative resection margins and an early favorable outcome despite a postoperative complication. The reported R0 status describes the morphological assessment of resection margins. Longer follow-up is required to assess durable disease control.
SN - 2077-0383
ER -